(thieno[2,3-b][1,5]benzoxazepin-4-yl)piperazin-1-yl compounds as dual activity H1 inverse agonists/5-HT 2A antagonists
- 专利权人:
- Eli Lilly and Company
- 发明人:
- Ledgard, Andrew James
- 申请号:
- AU2012300451
- 公开号:
- AU2012300451B2
- 申请日:
- 2012.08.22
- 申请国别(地区):
- AU
- 年份:
- 2016
- 代理人:
- 摘要:
- A dual H1 inverse agonist/5-HT
- 来源网站:
- 中国工程科技知识中心
相关发明人
相关专利
- (thieno[2,3-b][1,5]benzoxazepin-4-yl)piperazin-1-yl compounds as dual activity H1 inverse agonists/5-HT2A antagonists
- (THIENO[2,3-b][1,5]BENZOXAZEPIN-4-YL)PIPERAZIN-1-YL COMPOUNDS AS DUAL ACTIVITY H1 INVERSE AGONISTS/5-HT2A ANTAGONISTS
- Substituted [(5H-pyrrolo[2,1-c] [1,4]benzodiazepin-11-yl)piperazin-1-yl]-2,2-dimethylpropanoic acid compounds as dual activity H1 inverse agonists/5-HT2A antagonists
- (THIENO[2,3-b][1,5]BENZOXAZEPIN-4-YL)PIPERAZIN-1-YL COMPOUNDS AS COMPOUNDS HAVING DUAL ACTIVITY OF H1 INVERSE AGONISTS/5-HTANTAGONISTS
- H1 /5-HT2A [5H-[21-c][14]-11--1-]-22- SUBSTITUTED [5H-PYRROLO[21-c][14]BENZODIAZEPIN-11-YLPIPERAZIN-1-YL]-22-DIMETHYLPROPANOIC ACID COMPOUNDS AS DUAL ACTIVITY H1 INVERSE AGONISTS/5-HT2A ANTAGONISTS